carbidopa and Demyelinating Diseases

carbidopa has been researched along with Demyelinating Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H1
Mercimek-Mahmutoglu, S; Stockler-Ipsiroglu, S1

Other Studies

2 other study(ies) available for carbidopa and Demyelinating Diseases

ArticleYear
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
    The Tohoku journal of experimental medicine, 2006, Volume: 209, Issue:2

    Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome

2006
Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
    The Tohoku journal of experimental medicine, 2007, Volume: 211, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Basal Ganglia; Brain Diseases, Metabolic; Carbidopa; Cerebellum; Demyelinating Diseases; Dystonia; Female; Folic Acid Deficiency; Humans; Leucovorin; Levodopa; Male; Syndrome; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex

2007